These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10813379

  • 1. Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.
    Intengan HD, Schiffrin EL.
    J Cardiovasc Pharmacol; 2000 May; 35(5):763-8. PubMed ID: 10813379
    [Abstract] [Full Text] [Related]

  • 2. Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.
    Intengan HD, Schiffrin EL.
    Hypertension; 2000 Jun; 35(6):1221-5. PubMed ID: 10856267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM.
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
    Weber K, Bohmeke T, van der Does R, Taylor SH.
    Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q, Brassard P, Javeshghani DM, Iglarz M, Webb RL, Amiri F, Schiffrin EL.
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppressive action of docosahexaenoic acid enriched-Euglena on reduction of endothelium-dependent relaxation in stroke-prone spontaneously hypertensive rats (SHRSP).
    Murakami T, Ogawa H, Hayashi M, Yoshizumi H.
    J Nutr Sci Vitaminol (Tokyo); 1997 Apr; 43(2):211-23. PubMed ID: 9219094
    [Abstract] [Full Text] [Related]

  • 17. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC, Campbell WG, Nelson AH, Feuerstein GZ.
    J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
    Xiaozhen H, Yun Z, Mei Z, Yu S.
    Blood Press; 2010 Feb; 19(1):40-7. PubMed ID: 20001392
    [Abstract] [Full Text] [Related]

  • 20. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
    Teisman AC, Pinto YM, Buikema H, Flesch M, Böhm M, Paul M, van Gilst WH.
    J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.